- Home
- ADMA vs CBZ Comparison
ADMA vs CBZ Comparison
Compare ADMA & CBZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- CBZ
- Stock Information
- Founded
- ADMA 2004
- CBZ 1987
- Country
- ADMA United States
- CBZ United States
- Employees
- ADMA N/A
- CBZ N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- CBZ Business Services
- Sector
- ADMA Health Care
- CBZ Consumer Discretionary
- Exchange
- ADMA Nasdaq
- CBZ Nasdaq
- Market Cap
- ADMA 3.7B
- CBZ 3.5B
- IPO Year
- ADMA N/A
- CBZ N/A
- Fundamental
- Price
- ADMA $15.05
- CBZ $53.57
- Analyst Decision
- ADMA Strong Buy
- CBZ
- Analyst Count
- ADMA 3
- CBZ 0
- Target Price
- ADMA $27.67
- CBZ N/A
- AVG Volume (30 Days)
- ADMA 3.1M
- CBZ 561.9K
- Earning Date
- ADMA 11-06-2025
- CBZ 10-29-2025
- Dividend Yield
- ADMA N/A
- CBZ N/A
- EPS Growth
- ADMA 469.09
- CBZ N/A
- EPS
- ADMA 0.85
- CBZ 1.84
- Revenue
- ADMA $474,174,000.00
- CBZ $2,420,673,000.00
- Revenue This Year
- ADMA $21.17
- CBZ $56.99
- Revenue Next Year
- ADMA $26.03
- CBZ $5.51
- P/E Ratio
- ADMA $17.41
- CBZ $29.26
- Revenue Growth
- ADMA 43.58
- CBZ 46.49
- 52 Week Low
- ADMA $13.50
- CBZ $50.51
- 52 Week High
- ADMA $25.67
- CBZ $90.13
- Technical
- Relative Strength Index (RSI)
- ADMA 47.74
- CBZ 45.49
- Support Level
- ADMA $14.35
- CBZ $50.78
- Resistance Level
- ADMA $15.60
- CBZ $53.92
- Average True Range (ATR)
- ADMA 0.52
- CBZ 1.66
- MACD
- ADMA 0.13
- CBZ 0.13
- Stochastic Oscillator
- ADMA 65.17
- CBZ 45.45
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About CBZ CBIZ Inc.
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.